Labcorp Stock - Analyst and consensus view at the start of the week

Labcorp stock opens the new week without fresh company news, so investors are looking more closely at the current analyst ratings and earnings expectations. A look at the consensus estimates and the testing specialist’s business profile provides orientation.

Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/22/2026, 10:07 UTC. Details in the imprint.

Labcorp (US50540R4092) starts the new week without a fresh market-moving filing or press release, so the focus turns to the current analyst consensus and upcoming earnings expectations as investors position around the diagnostics and drug-development stock.

What analysts expect today

Labcorp is followed by a broad group of Wall Street banks and research houses, with most ratings clustered in the Buy and Hold range according to current analyst-summary data on major financial portals.

The consensus view points to modest earnings growth over the next 12 to 18 months, reflecting expectations of steady demand in clinical diagnostics and contract research services rather than rapid expansion.

Consensus earnings and revenue picture

For the coming quarters, analysts generally model low single-digit revenue growth and a stable margin profile, underpinned by routine testing volumes and ongoing projects for pharmaceutical and biotech customers.

On balance, this results in earnings-per-share estimates that edge up gradually year on year, signaling confidence in Labcorp’s ability to translate its diversified portfolio into steady cash generation.

How Labcorp makes its money

Labcorp generates most of its revenue from laboratory testing and diagnostic services for physicians, hospitals and patients, complemented by a large contract research operation that supports clinical trials and drug development for pharmaceutical and biotechnology companies worldwide.

Where the stock trades today

Labcorp stock (US50540R4092) trades on the New York Stock Exchange in US dollars; the latest available quote data will determine the exact price and market value at the time of reading.

Key facts on Labcorp stock

• Company: Laboratory Corporation of America Holdings
• ISIN: US50540R4092
• Ticker: LH
• Venue: NYSE
• Sector / Industry: Health Care - Diagnostics and Research

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.